• Revenue up 14.8% to $6.1M
• Loss increased 3.3% to $6.1M
• Net tangible assets per share at $0.49

Control Bionics Limited has reported its preliminary financial results for the year ended 30 June 2025. The company's revenue from ordinary activities increased by 14.84% to $6,144,907, while the loss from ordinary activities after tax attributable to the owners of Control Bionics Limited increased by 3.30% to $6,108,667. The loss for the year attributable to the owners of Control Bionics Limited also increased by 3.30% to $6,108,667. There were no dividends paid, recommended or declared for the current financial year. The net tangible assets per ordinary security stood at 0.49 cents as at 30 June 2025, compared to 0.93 cents as at 30 June 2024. The company's financial statements are currently in the process of being audited, and the audited financial statements are likely to include an emphasis of matter related to a material uncertainty that may cast significant doubt on the Group's ability to continue as a going concern, consistent with the prior year.